126 related articles for article (PubMed ID: 26074705)
1. Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients.
Zhou P; Xia J; Zhou YJ; Wan J; Li L; Bao J; Shi YJ; Bu H
World J Gastroenterol; 2015 Jun; 21(21):6665-74. PubMed ID: 26074705
[TBL] [Abstract][Full Text] [Related]
2. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
Hassan EA; Abd El-Rehim AS
Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
[TBL] [Abstract][Full Text] [Related]
3. Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes.
Shi Y; Sun H; Bao J; Zhou P; Zhang J; Li L; Bu H
Am J Pathol; 2011 Sep; 179(3):1138-47. PubMed ID: 21763259
[TBL] [Abstract][Full Text] [Related]
4. Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
Kerbert AJ; Verbeke L; Chiang FW; Laleman W; van der Reijden JJ; van Duijn W; Nevens F; Wolterbeek R; van Hoek B; Verspaget HW; Coenraad MJ
PLoS One; 2015; 10(9):e0138264. PubMed ID: 26378453
[TBL] [Abstract][Full Text] [Related]
5. Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.
Kerbert AJ; Weil D; Verspaget HW; Moréno JP; van Hoek B; Cervoni JP; Di Martino V; Coenraad MJ; Thevenot T
Liver Int; 2016 Apr; 36(4):530-7. PubMed ID: 26502363
[TBL] [Abstract][Full Text] [Related]
6. Plasma copeptin, a possible prognostic marker in cirrhosis.
Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
[TBL] [Abstract][Full Text] [Related]
7. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
Xia R; Zhou R; Tian Z; Zhang C; Wang L; Hu Y; Han J; Li J
Arch Pathol Lab Med; 2013 Dec; 137(12):1761-9. PubMed ID: 24283856
[TBL] [Abstract][Full Text] [Related]
8. Elaboration of tubules with active hedgehog drives parenchymal fibrogenesis in gestational alloimmune liver disease.
Asai A; Malladi S; Misch J; Pan X; Malladi P; Diehl AM; Whitington PF
Hum Pathol; 2015 Jan; 46(1):84-93. PubMed ID: 25387814
[TBL] [Abstract][Full Text] [Related]
9. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis.
Nishida T; Tsuji S; Tsujii M; Arimitsu S; Haruna Y; Imano E; Suzuki M; Kanda T; Kawano S; Hiramatsu N; Hayashi N; Hori M
Am J Gastroenterol; 2006 Jan; 101(1):70-5. PubMed ID: 16405536
[TBL] [Abstract][Full Text] [Related]
10. Cardiac and proinflammatory markers predict prognosis in cirrhosis.
Wiese S; Mortensen C; Gøtze JP; Christensen E; Andersen O; Bendtsen F; Møller S
Liver Int; 2014 Jul; 34(6):e19-30. PubMed ID: 24313898
[TBL] [Abstract][Full Text] [Related]
11. Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.
Vogt A; Reuken PA; Stengel S; Stallmach A; Bruns T
World J Gastroenterol; 2016 Mar; 22(11):3275-84. PubMed ID: 27004006
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J
Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
14. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
15. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis.
Delhaye M; Louis H; Degraef C; Le Moine O; Devière J; Gulbis B; Jacobovitz D; Adler M; Galand P
Hepatology; 1996 May; 23(5):1003-11. PubMed ID: 8621125
[TBL] [Abstract][Full Text] [Related]
16. Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis.
Mathur S; Peng S; Gane EJ; McCall JL; Plank LD
Nutrition; 2007 May; 23(5):398-403. PubMed ID: 17395427
[TBL] [Abstract][Full Text] [Related]
17. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
Trerè D; Borzio M; Morabito A; Borzio F; Roncalli M; Derenzini M
Hepatology; 2003 Jan; 37(1):72-8. PubMed ID: 12500191
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
